Post-Transplant Cyclophosphamide Combined with Brilliant Blue G Reduces Graft-versus-Host Disease without Compromising Graft-versus-Leukaemia Immunity in Humanised Mice
Peter Cuthbertson(Migration Institute of Australia), Ronald Sluyter(University of Wollongong), Debbie Watson(University of Wollongong), Kara L. Vine(University of Wollongong), Amy Button(University of Wollongong), Chloe Sligar(University of Wollongong), Amal Elhage(University of Wollongong)
Cited by 5
Related Papers
Towards clinical translation of ligand-functionalized liposomes in targeted cancer therapy: Challenges and opportunities
|Journal of Controlled Release|2018|297
Cytotoxic and Anticancer Activities of Isatin and Its Derivatives: A Comprehensive Review from 2000-2008
|Anti-Cancer Agents in Medicinal Chemistry|2009|269
Biopolymers for Antitumor Implantable Drug Delivery Systems: Recent Advances and Future Outlook
|Advanced Materials|2018|217
In vitro cytotoxicity evaluation of some substituted isatin derivatives
|Bioorganic & Medicinal Chemistry|2006|193
An Investigation into the Cytotoxicity and Mode of Action of Some Novel <i>N</i>-Alkyl-Substituted Isatins
|Journal of Medicinal Chemistry|2007|150